30 Mar 2026
IM8's Superpower Biomarker Testing Partner Adds Data-Driven Health Layer; Raise Estimates Based on Partnership, Stock Buybacks, Sidoti Conference Comments; Maintain $30 Price Target
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
IM8's Superpower Biomarker Testing Partner Adds Data-Driven Health Layer; Raise Estimates Based on Partnership, Stock Buybacks, Sidoti Conference Comments; Maintain $30 Price Target
- Published:
30 Mar 2026 -
Author:
Alex Hantman -
Pages:
10 -